Found: 18
Select item for more details and to access through your institution.
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
- Published in:
- Cancer & Metastasis Reviews, 2016, v. 35, n. 4, p. 515, doi. 10.1007/s10555-016-9637-x
- By:
- Publication type:
- Article
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 251, doi. 10.1007/s10549-019-05374-x
- By:
- Publication type:
- Article
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 115, doi. 10.1007/s10549-019-05296-8
- By:
- Publication type:
- Article
Patrón serológico anómalo de reactivación del virus de la hepatitis B en 2 pacientes en tratamiento con alemtuzumab.
- Published in:
- Revista Española de Quimioterapia, 2013, v. 26, n. 3, p. 228
- By:
- Publication type:
- Article
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09068-2
- By:
- Publication type:
- Article
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4705, doi. 10.3390/cancers14194705
- By:
- Publication type:
- Article
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63637-w
- By:
- Publication type:
- Article
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55765-9
- By:
- Publication type:
- Article
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82671-w
- By:
- Publication type:
- Article
Trajectories of alcohol consumption during life and the risk of developing breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID‐19 Pandemic in Spain.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. e1339, doi. 10.1634/theoncologist.2020-0363
- By:
- Publication type:
- Article
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-19291-x
- By:
- Publication type:
- Article
Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype.
- Published in:
- Nutrients, 2020, v. 12, n. 10, p. 3132, doi. 10.3390/nu12103132
- By:
- Publication type:
- Article
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A polymorphism at the 3′-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.
- Published in:
- BMC Cancer, 2010, v. 10, p. 1, doi. 10.1186/1471-2407-10-36
- By:
- Publication type:
- Article